Sharing COVID-19 experiences: the El Salvador response
Date:
27/02/2021
El Salvador responded rapidly and effectively to the emergence of the SARS-CoV-2 virus in the country. In line with WHO advice, El Salvador stepped up preparedness of its health system in mid-January and announced a national emergency on 30 January, the same day that WHO declared COVID-19 a public health emergency of international concern. El Salvador’s strong response has been built on equippin...
See more details
Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Betacoronavirus/immunology, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Epidemiological Monitoring, El Salvador/epidemiology, Health Systems/organization & administration, Quarantine/organization & administration, Social Isolation, Access to Essential Medicines and Health Technologies, Polymerase Chain Reaction/methods, Health Personnel/education, COVID-19
Live: Dr Tedros' opening remarks at the Executive Board Special Session on COVID-19
Date:
05/10/2020
See more details
Betacoronavirus/immunology, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology, Coronavirus Infections/immunology, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Pandemics/statistics & numerical data, Health Systems/organization & administration, Epidemiological Monitoring, Quarantine/organization & administration, Social Isolation, Personal Protective Equipment/supply & distribution, Healthcare Financing, Masks, Polymerase Chain Reaction/methods, Security Measures/organization & administration, Health Personnel/education, Health Human Resource Training, 50207, Strategic Stockpile/organization & administration, Viral Vaccines/immunology, Viral Vaccines/supply & distribution, Dexamethasone/therapeutic use, Health Communication, COVID-19, Ghebreyesus, Tedros Adhanom, Covax
Media briefing on COVID-19 - 28/09/2020
Date:
28/09/2020
See more details
Betacoronavirus/genetics, Betacoronavirus/immunology, Betacoronavirus/isolation & purification, Coronavirus Infections/genetics, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pneumonia, Viral/genetics, Polymerase Chain Reaction/methods, Polymerase Chain Reaction/statistics & numerical data, Public-Private Sector Partnerships/economics, Epidemiological Monitoring, Pandemics/prevention & control, Viral Vaccines/immunology, Viral Vaccines/supply & distribution, Access to Essential Medicines and Health Technologies, Health Systems/organization & administration, Social Isolation, Quarantine/organization & administration, Universal Access to Health Care Services, COVID-19, Covax, Ghebreyesus, Tedros Adhanom
COVID-19 live Q&A with Dr Mike Ryan and Dr Maria Van Kerkhove. Ask WHO of 23 September 2020
Date:
23/09/2020
#AskWHO series: This was the live discussion about the COVID-19 pandemic of 23 September 2020 with Dr Mike Ryan, Executive Director of WHO Health Emergencies Programme, and Dr Maria Van Kerkhove, WHO Technical Lead on COVID-19. Questions from the audience were taken.
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Coronavirus Infections/diagnosis, Pandemics/prevention & control, Health Promotion, Epidemiological Monitoring, Pneumonia, Viral/diagnosis, Social Isolation, Quarantine/organization & administration, Masks, Polymerase Chain Reaction/methods, Health Systems/organization & administration, Public Health Laboratory Services, DNA, Viral/genetics, Betacoronavirus/genetics, COVID-19
OPS COVID-19 Conferencia de Prensa - 16 de septiembre 2020
Date:
16/09/2020
OPS COVID-19 Conferencia de Prensa - 16 de septiembre 2020 - audio español
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Quarantine/organization & administration, Epidemiological Monitoring, Vulnerable Populations, Risk Groups, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Public Sector/economics, Commerce/organization & administration, Social Isolation, Social Protection in Health/policies, Hand Disinfection, Schools/standards, Travel-Related Illness, e-Government, Health Systems/organization & administration, Clinical Trial, Phase III, Viral Vaccines/adverse effects, Healthy Volunteers, Strategic Stockpile/organization & administration, Personal Protective Equipment/supply & distribution, Masks, Polymerase Chain Reaction, COVID-19, Etienne, Carissa F
Sesión informativa para prensa de la OPS sobre COVID-19
Date:
16/09/2020
OPS COVID-19 Conferencia de Prensa - 16 de septiembre 2020 - audio original
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Quarantine/organization & administration, Epidemiological Monitoring, Vulnerable Populations, Risk Groups, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Public Sector/economics, Commerce/organization & administration, Social Isolation, Social Protection in Health/policies, Hand Disinfection, Schools/standards, Travel-Related Illness, e-Government, Health Systems/organization & administration, Clinical Trial, Phase III, Viral Vaccines/adverse effects, Healthy Volunteers, Strategic Stockpile/organization & administration, Personal Protective Equipment/supply & distribution, Masks, Polymerase Chain Reaction, COVID-19, Etienne, Carissa F
PAHO-WHO information session for the press on COVID19 - September 16, 2020
Date:
16/09/2020
OPS COVID-19 Conferencia de Prensa - 16 de septiembre 2020 - audio english
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Quarantine/organization & administration, Epidemiological Monitoring, Vulnerable Populations, Risk Groups, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Public Sector/economics, Commerce/organization & administration, Social Isolation, Social Protection in Health/policies, Hand Disinfection, Schools/standards, Travel-Related Illness, e-Government, Health Systems/organization & administration, Clinical Trial, Phase III, Viral Vaccines/adverse effects, Healthy Volunteers, Strategic Stockpile/organization & administration, Personal Protective Equipment/supply & distribution, Masks, Polymerase Chain Reaction, COVID-19, Etienne, Carissa F
COVID-19 live Q&A with Dr Mike Ryan and Dr Maria Van Kerkhove. Ask WHO of 16 September 2020
Date:
16/09/2020
#AskWHO series: This was the live discussion about the COVID-19 pandemic of 16 September 2020 with Dr Mike Ryan, Executive Director of WHO Health Emergencies Programme, and Dr Maria Van Kerkhove, WHO Technical Lead on COVID-19. Questions from the audience were taken.
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Epidemiological Monitoring, Quarantine/organization & administration, Social Isolation, Influenza Vaccines/immunology, Hospital Bed Capacity, Health Systems/organization & administration, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Dexamethasone/therapeutic use, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Personal Protective Equipment/supply & distribution, Risk Groups, Schools/organization & administration, Betacoronavirus/immunology, Masks, Betacoronavirus/genetics, Viral Vaccines/immunology, Polymerase Chain Reaction, COVID-19
COVID-19 live about ACT-Accelerator and COVAX: Dr Swaminathan, Dr Somao. Ask WHO of 9 Sept. 2020
Date:
09/09/2020
#AskWHO series: This was the live discussion of 9 September 2020 about the ACT-Accelerator and COVAX to fight the COVID-19 pandemic, with Dr Soumya Swaminathan @doctorsoumya, WHO Chief Scientist, and Dr Mariângela Simão @mariangelasimao, WHO Assistant Director-General, Access to Medicines and Health Products. Questions from the audience were taken.
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/immunology, Public-Private Sector Partnerships/organization & administration, Clinical Trial Protocol, Vaccine Potency, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Health Systems/organization & administration, Polymerase Chain Reaction/methods, Epidemiological Monitoring, Quarantine/organization & administration, Social Isolation, Health Personnel/organization & administration, Access to Essential Medicines and Health Technologies, COVID-19, Covax, ACT-Accelerator
Pregunte al experto: eliminación de enfermedades infecciosas durante COVID-19
Date:
04/09/2020
Dengue, Malaria, Parásitos intestinales, VIH, Tuberculosis, Hepatitis, VPH...
¿Amenaza la COVID-19 su eliminación?
See more details
Communicable Diseases/epidemiology, Communicable Disease Control/organization & administration, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Betacoronavirus, Health Systems/organization & administration, Epidemiological Monitoring, Americas/epidemiology, Vector Borne Diseases/transmission, Health Promotion/organization & administration, 50207, Dengue/prevention & control, Malaria/prevention & control, Health Services Accessibility/organization & administration, Tuberculosis/prevention & control, Telemedicine/methods, 51352, Aedes/virology, Housing Sanitation, Patient Care Management/organization & administration, Symptom Flare Up, Primary Health Care/organization & administration, Maternal Health, Prenatal Care, Polymerase Chain Reaction/methods, Social Isolation, Quarantine/organization & administration, Helminthiasis/prevention & control, COVID-19
